Paper · 2026
[T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?]
PubMed, 106(33), 3423–3430 · Published 8 September 2026 · DOI 10.3760/cma.j.cn112137-20260330-00853
In brief
“[T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?]” is a 2026 paper by Q B Li and 3 co-authors, published in PubMed. OpenAlex counts 0 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 4
Abstract
The treatment of rheumatic diseases (RMD) is still challenged by long-term treatment dependence and refractory relapses. Therapeutic goals are therefore shifting from suppression of inflammation toward deep B-cell depletion and immune resetting. Conventional B-cell-depleting monoclonal antibodies have insufficient capacity for tissue B-cell depletion. Autologous chimeric antigen receptor T-cell (CAR-T) therapy has shown the potential for… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, Q. B., Guan, X., Mei, C., & Xu, J. (2026). [T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?]. PubMed, 106(33), 3423–3430. https://doi.org/10.3760/cma.j.cn112137-20260330-00853
MLA 9
Li, Q B, et al. “[T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?].” PubMed, vol. 106, no. 33, 2026, pp. 3423–3430. https://doi.org/10.3760/cma.j.cn112137-20260330-00853.
Chicago
Li, Q B, X Guan, Chunli Mei, and Jason Xu. 2026. “[T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?].” PubMed 106 (33): 3423–3430. https://doi.org/10.3760/cma.j.cn112137-20260330-00853.
Harvard
Li, Q. B. et al. (2026) ‘[T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?]’, PubMed, 106(33), pp. 3423–3430. doi:10.3760/cma.j.cn112137-20260330-00853.
IEEE
Q. B. Li, X. Guan, C. Mei, and J. Xu, “[T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?],” PubMed, vol. 106, no. 33, pp. 3423–3430, 2026, doi: 10.3760/cma.j.cn112137-20260330-00853.
BibTeX
@article{li2026cell,
title = {{[T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?]}},
author = {Li, Q B and Guan, X and Mei, Chunli and Xu, Jason},
journal = {PubMed},
year = {2026},
volume = {106},
number = {33},
pages = {3423--3430},
doi = {10.3760/cma.j.cn112137-20260330-00853},
url = {https://doi.org/10.3760/cma.j.cn112137-20260330-00853}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- T-cell engagers
- B-cell depletion
- rheumatic diseases
- CD19
- CD20
- BCMA
- systemic lupus erythematosus
- systemic sclerosis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Li, Q. B., Guan, X., Mei, C., & Xu, J. (2026). [T-cell engagers: a transformative force or a redundant option in B-cell depletion therapy for rheumatic diseases?]. PubMed, 106(33), 3423–3430. https://doi.org/10.3760/cma.j.cn112137-20260330-00853
How many times has this paper been cited?
0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Q B Li, X Guan, Chunli Mei, Jason Xu.
What is the DOI of this paper?
10.3760/cma.j.cn112137-20260330-00853, permanently at https://doi.org/10.3760/cma.j.cn112137-20260330-00853. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.